Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function.

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Abstract Text:

Carlo P Trevisan,Ebe Pastorello,Mario Ermani,Corrado Angelini,Giuliano Tomelleri,Paola Tonin,Tiziana Mongini,Laura Palmucci,Giuliana Galluzzi,Rossella G Tupler,Gino Marioni,Alessandro Rimini,Carlo P Trevisan,Ebe Pastorello,Mario Ermani,Corrado Angelini,Giuliano Tomelleri,Paola Tonin,Tiziana Mongini,Laura Palmucci,Giuliana Galluzzi,Rossella G Tupler,Gino Marioni,Alessandro Rimini,

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant progressive myopathy, characteristically associated with a 4q35 deletion. In the unusual infantile-onset form of this degenerative disease, sensorineural hearing loss is a frequent clinical manifestation, whereas in patients with typical late-onset FSHD, investigations regarding hearing impairment yielded controversial results. We describe the findings of a multicenter investigation on possible auditory impairment in a series of 73 FSHD patients with a genetically confirmed diagnosis. Among them, 49 cases with no risk factors for deafness, aside from the disease, were identified by a clinical questionnaire and otoscopic examination (mean age 37.8 years, 31 males and 18 females). These subjects were evaluated by pure-tone audiometry. None were aware of hearing loss, while 4 had raised unilateral or bilateral pure-tone audiometric thresholds at 4000 and 8000 Hz, when evaluated by standardized tables. However, the mean raw pure-tone audiometric threshold values for these 49 cases were not significantly different from those of 55 controls (mean age 37.1 years, 32 males and 23 females). Moreover, by statistical analysis, age of onset, degree of muscular weakness and 4q35 EcoRI fragment size made no significant difference to auditory thresholds in our FSHD patients. Overall, the results of our multicenter study suggest that hearing loss in typical FSHD is not more prevalent than in the normal population.

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Publishing Authors By Initials

CP Trevisan,E Pastorello,M Ermani,C Angelini,G Tomelleri,P Tonin,T Mongini,L Palmucci,G Galluzzi,RG Tupler,G Marioni,A Rimini,CP Trevisan,E Pastorello,M Ermani,C Angelini,G Tomelleri,P Tonin,T Mongini,L Palmucci,G Galluzzi,RG Tupler,G Marioni,A Rimini,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Audiology & neuro-otology

VOLUME: 13

Page Numbers: 1-6

Journal Abbreviation: Audiol. Neurootol.

ISSN: 1421-9700

DAY: 22

MONTH: 08

YEAR: 2007

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9606930

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function.

AFFILIATION: Department of Neurological and Psychiatric Sciences, University of Padua, Padua, Italy. carlopietro.trevisan@unipd.it

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Audiol Neurootol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function Related Publications

• Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function.